Kozakiewicz K, Wróbel M, Petelenz T, Lepkowski A, Skrzypek-Wańha J, Chruściel T L
III Kliniki Kardiologii Sl. AM, Katowicach.
Pol Tyg Lek. 1993;48(14-15):327-9.
Therapeutic effects of TMZ treatment were evaluated in 31 patients with atrio-cochlear disorders caused by an insufficiency of cerebral circulation. It was found that the results of vestibular or cochlear disorders remission was dependent on the time interval between the onset of symptoms and the beginning of trimetazidine therapy. The best results were also found in patients suffering from atrio-cochlear disorders lasting not longer than two years and due to arterial hypertension or cerebral basilar artery insufficiency.
对31例因脑循环不足引起的心房-耳蜗障碍患者评估了曲美他嗪治疗的疗效。发现前庭或耳蜗障碍缓解的结果取决于症状出现与曲美他嗪治疗开始之间的时间间隔。在患有持续时间不超过两年且由动脉高血压或脑基底动脉供血不足引起的心房-耳蜗障碍的患者中也发现了最佳结果。
